Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Corvus Pharmaceuticals is a US-based biopharmaceutical company specializing in the development of innovative therapies for cancer and autoimmune diseases. The company focuses on the research of targeted immunotherapies aimed at improving patient care and advancing medical treatment standards.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Corvus Pharmaceuticals is scheduled to report its next quarterly earnings on 10/29/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Corvus Pharmaceuticals last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -0.19 USD.
Across its last 3 earnings reports, Corvus Pharmaceuticals stock moved by ±3.8% on average the following day. The largest reaction was +6.6% on 05/07/2026; 2 of 3 reactions were positive.
Corvus Pharmaceuticals has beaten analyst EPS estimates in 1 of its last 5 evaluated quarters (beat rate: 20%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.